clarithromycin vs placebo | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Acute coronary syndrome | 1.02 [0.81 1.27] | p=1.00 | 0 | 4521 | 2 | CLARIFY,CLARICOR, | cardiovascular events | 1.17 [0.99 1.39] | p=1.00 | 0 | 4373 | 1 | CLARICOR, | myocardial infarction (fatal and non fatal) | 0.52 [0.18 1.50] | p=1.00 | 0 | 181 | 1 | CLARIFY, | Coronary event | 1.14 [0.96 1.34] | p=1.00 | 0 | 4373 | 1 | CLARICOR, | All cause death | 1.17 [0.94 1.45] | p=1.00 | 0 | 4521 | 2 | CLARIFY,CLARICOR, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |